A 2026 informational evaluation of MEDVi's GLP-1 weight loss program structure, compounded semaglutide and branded Ozempic ...

The highest dose of Eli Lilly’s investigational drug, retatrutide, helped adults with Type 2 diabetes lower their A1Cs about 2% and shed an average 33.3 pounds, or 15.3% of their body weight, in a ...

Mt Baker Medical is excited to unveil its newly developed physician-supervised GLP-1 weight loss initiative, aimed at delivering safe and effective solutions for medical weight management. This ...

Starting July 1, Medicare Part D beneficiaries can get GLP-1 weight loss medications for $50 per month, subject to certain ...

Walgreens is expanding its Virtual Healthcare platform with the launch of a new digital health offering, Walgreens Weight Management, which connects individuals with licensed doctors and nurse ...

The new platform lets employers offer GLP-1 drugs like Zepbound at a discounted rate while choosing from a marketplace of administrators.

Glucagon-like peptide-1 receptor agonists (GLP-1s) are a class of medication that includes Ozempic®, Wegovy®, and Saxenda®. Some GLP-1s are diabetes drugs, but you can also take a GLP-1 for weight ...

A 2026 informational consumer research report examining the TMates telehealth weight-loss platform, compounded GLP-1 ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

The Wu administration is considering dropping GLP-1 coverage for weight loss for City of Boston employees due to ...